Autoimmune Diabetes Accelerator Prevention Trial

Summary

Autoimmune Diabetes Accelerator Prevention Trial is a clinical trial^[1].

Key Facts

• Autoimmune Diabetes Accelerator Prevention Trial is in the country of United Kingdom^[2].
• Autoimmune Diabetes Accelerator Prevention Trial's instance of is recorded as clinical trial^[3].
• Autoimmune Diabetes Accelerator Prevention Trial's start time is recorded as +2016-03-30T00:00:00Z^[4].
• Autoimmune Diabetes Accelerator Prevention Trial's end time is recorded as +2017-06-30T00:00:00Z^[5].
• Autoimmune Diabetes Accelerator Prevention Trial's contributor to the creative work or subject is recorded as University of Bristol^[6].
• Autoimmune Diabetes Accelerator Prevention Trial's number of participants is recorded as {'unit': '1', 'amount': '+0'}^[7].
• Autoimmune Diabetes Accelerator Prevention Trial's title is recorded as Autoimmune Diabetes Accelerator Prevention Trial - adAPT Stage 1^[8].
• Autoimmune Diabetes Accelerator Prevention Trial's short name is recorded as adAPT^[9].
• Autoimmune Diabetes Accelerator Prevention Trial's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+5'}^[10].
• Autoimmune Diabetes Accelerator Prevention Trial's ClinicalTrials.gov ID is recorded as NCT02881528^[11].
• Autoimmune Diabetes Accelerator Prevention Trial's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+16'}^[12].
• Autoimmune Diabetes Accelerator Prevention Trial's research intervention is recorded as metformin^[13].
• Autoimmune Diabetes Accelerator Prevention Trial's clinical trial phase is recorded as phase IV clinical trial^[14].
• Autoimmune Diabetes Accelerator Prevention Trial's research site is recorded as NHS Grampian^[15].
• Autoimmune Diabetes Accelerator Prevention Trial's research site is recorded as NHS Tayside^[16].
• Autoimmune Diabetes Accelerator Prevention Trial's study type is recorded as interventional study^[17].